The product information provided on our website is intended for residents of the United States.
Heron Therapeutics, Inc. does not accept or consider unsolicited ideas submitted through or in connection with the website. Notwithstanding the foregoing, you agree that any feedback, information, suggestions, ideas or materials (e.g., text, photographs, caricatures, illustrations, designs, icons, articles, audio clips, and video clips, etc.) you submit through or in connection with this website (each, an “idea”) will not be subject to any use or disclosure restrictions and will be considered non-confidential by us. By providing ideas to us you agree that we shall have, at no charge, a non-exclusive, transferable, royalty free, perpetual, irrevocable, worldwide right and license to reproduce distribute, display, perform and create derivative works of such ideas and to use, make, offer for sale, sell and import products containing or based on such ideas. We shall be free to use and disseminate such ideas on an unrestricted basis for any purpose. In addition, we do not control ideas posted or otherwise transmitted via this website by others and we do not guarantee the accuracy, integrity, or quality of such ideas. Any communications you send to this website or otherwise to Heron Therapeutics, Inc. by electronic mail, with the exception of personally identifiable information as defined in the Internet Privacy Statement, shall be deemed to be non-confidential.
Our policies concerning the use of your personal information are set forth in the Internet Privacy Statement on this website and incorporated by reference herein. By using this website or the services provided by or through this website (“services”), you agree to waive and release Heron Therapeutics, Inc. from any claim or liability in connection with the collection, use, or disclosure of information consistent with the Internet Privacy Statement.
The Site Content is provided for informational purposes only and should not be construed as medical, legal, financial, investment, or other professional advice or opinion. We do not offer personalized medical advice or patient-specific treatment advice. Only your doctor or other healthcare professional can determine if a product described on this website is appropriate for you. Use of this website is not a substitute for a call or visit to, or consultation with, your physician or a healthcare professional. You should not rely on this website or any other service offered by or through this website for medical diagnosis or treatment. YOU SHOULD NEVER DISREGARD OR DELAY SEEKING MEDICAL ADVICE BECAUSE OF SOMETHING THAT YOU HAVE SEEN OR HEARD ON THIS WEBSITE. PLEASE CONSULT WITH YOUR DOCTOR, OR OTHER QUALIFIED HEALTHCARE PROFESSIONAL, BEFORE USING ANY PRODUCT DISCUSSED ON THIS WEBSITE.
The Site Content is for your general education only and is not intended to provide advice or guidance or to be used for any commercial purpose. The Site Content may be out of date or include omissions or other errors. In particular, we may not update our website on a daily or other regular basis. We may update or otherwise change the Site Content at any time without notice. The identification or description of products or services of Heron Therapeutics, Inc. or third parties on the website is for informational purposes only and does not constitute a representation, warranty, guarantee, endorsement or recommendation of such products and services. All Site Content is provided “AS IS” and “AS AVAILABLE” without warranty of any kind. To the maximum extent permitted by law, Heron Therapeutics, Inc. and its affiliates and partners disclaim all warranties, express or implied, regarding the website and the Site Content therein, including the implied warranties of merchantability, fitness for a particular purpose, and non-infringement of third party rights.
We make no warranty that this website will meet your requirements; that this website will be uninterrupted, timely, secure, or error free; that messages or requests will be delivered; that defects will be corrected; or that this website is free of viruses or other harmful components. We make no warranty regarding any goods or services purchased or obtained through this website or any transactions entered into through this website. You assume the entire risk as to the results and performance of this website and any goods or services purchased therefrom.
Limitation of Liability
Heron Therapeutics, Inc. its directors, officers, employees, affiliates, agents, representatives, consultants and business partners shall not be liable for any direct, indirect, special, punitive, consequential or incidental damages (including without limitation those arising from lost profits, lost data or business interruption) arising from or related to use, inability to use, or the result of use of the website or the materials, information or hyperlinks contained therein, or on any other hyperlinked website, whether based on warranty, contact, tort or any other legal theory, even if Heron Therapeutics, Inc. its directors, officers, employees, affiliates, agents, representatives, consultants or business partners have been expressly advised of the possibility of such damages. You agree to hold Heron Therapeutics, Inc., its directors, officers, employees, affiliates, agents, representatives, consultants and business partners harmless from and against any claims or actions based upon or related to the use of our website or any hyperlinked website or based on any reliance upon the information contained therein. Applicable law may not allow the exclusion or limitation of incidental or consequential damages so the above limitation or exclusion may not apply to you.
Use of this Website
You agree not to do any of the following while visiting or using this website or any services provided by or through this website:
- Impersonate or misrepresent your affiliation with any person or entity;
- Except as expressly permitted by the rules of this website, post or transmit any unsolicited advertising, promotional materials, junk mail, spam, or any other form of solicitation on this website or through the services;
- Post or transmit any information or material that is defamatory, offensive, indecent, obscene, or unlawful;
- Post or transmit any information or software which contains a virus, trojan horse, worm or other harmful components;
- Violate any applicable law or regulation, including without limitation any local, state, provincial, national or international law, any export control laws, or any regulations promulgated by any state or federal authority;
- Access or use password protected, secure or non-public areas of this website without authorization; or
- Frame, repackage, or otherwise re-distribute any portion of this website.
This website contains forward-looking statements within the meaning of the federal securities laws, specifically the Securities Litigation Reform Act of 1995, including without limitation, statements related to: the degree of commercial success of SUSTOL, CINVANTI, HTX-011, if approved, and any other product candidates that we commercialize; the scope, rate of progress, results and costs of preclinical testing and clinical trials; the timing and cost to manufacture our products; the number and characteristics of product development programs we pursue and the pace of each program, including the timing of clinical trials; the time, cost and outcome involved in seeking other regulatory approvals; scientific progress in our research and development programs; the magnitude and scope of our research and development programs; our ability to establish and maintain strategic collaborations or partnerships for research, development, clinical testing, manufacturing and marketing of our products and product candidates; the cost and timing of establishing sales, marketing and distribution capabilities if we commercialize products independently; the cost of establishing clinical and commercial supplies of our product candidates and any products that we may develop; general market conditions; the degree of commercial success of the continued development and clinical, therapeutic and commercial potential of, and opportunities, for HTX-011; whether the U.S. Food and Drug Administration approves the New Drug Application for HTX-011; the timing of the commercial launch of HTX-011, if approved; the timing of the European Medicines Agency Committee for Medicinal Products for Human Use’s review process for HTX-011; whether the European Commission authorizes the Marketing Authorisation Application for HTX-011; the continued development and clinical, therapeutic and commercial potential of, and opportunities, for Heron Therapeutics, Inc.’s partnered compounds and programs; future periods; future events; and future operating and financial plans and performance. Any statements contained in this website that are not statements of historical fact may be deemed to be forward-looking statements. Words such as “anticipates,” “believes,” “continue,” “demonstrate,” “estimates,” “expects,” “forecast,” “goal,” “intends,” “may,” “objective,” “outlook,” “plans,” “potential,” “should,” “will” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Heron Therapeutics, Inc.’s current plans, assumptions, beliefs and expectations. Forward-looking statements involve risks and uncertainties. Heron Therapeutics, Inc.’s actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation: risks related to the costs associated with the commercial launch of HTX-011, if approved; the degree of commercial success of SUSTOL, CINVANTI and HTX-011, if approved; the timing and cost to manufacture our products; the cost and timing of establishing sales, marketing and distribution capabilities for products we commercialize independently; the cost of establishing clinical and commercial supplies of our products and any product candidates that we may develop; the degree of commercial success of the continued development and clinical, therapeutic and commercial potential of, and opportunities, for HTX-011; whether the U.S. Food and Drug Administration approves the New Drug Application for HTX-011; the timing of the commercial launch of HTX-011, if approved; the timing of the Committee for Medicinal Products for Human Use’s review process for HTX-011; whether the European Commission authorizes the Marketing Authorisation Application for HTX-011; the number and characteristics of product development programs we pursue and the pace of each program, including the timing of clinical trials; the time, cost and outcome involved in seeking other regulatory approvals; scientific progress in our research and development programs; the sufficiency of Heron Therapeutics, Inc.’s capital and other resources; the uncertain timing and level of expenses associated with the development of HTX-011 and other product candidates that we develop; the uncertainty of the FDA approval process; risks related to the potential failure of Heron Therapeutics, Inc.’s partnered compounds and programs to demonstrate safety and efficacy in clinical testing; Heron Therapeutics, Inc.’s dependence on its relationships with its collaboration partners with respect to its partnered compounds and programs; Heron Therapeutics, Inc.’s ability to maintain its rights under its collaborative agreements; timely receipt of potential reimbursements, milestones, royalties and profits under Heron Therapeutics, Inc.’s collaborative agreements; Heron Therapeutics, Inc.’s ability to enter into new collaborations; market competition; and changes in economic and business conditions. These and other risk factors are discussed under “Risk Factors” and elsewhere in Heron Therapeutics, Inc.’s periodic reports filed with the Securities and Exchange Commission (SEC), including Heron Therapeutics, Inc.’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, and Heron Therapeutics, Inc.’s other filings with the SEC. Heron Therapeutics, Inc. expressly disclaims any duty, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this website to reflect any change in Heron Therapeutics, Inc.’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.
Our website may contain hyperlinks to websites owned or controlled by parties other than Heron Therapeutics, Inc. Access to any such website is at your own risk and we are not responsible for the accuracy or reliability of any information, data, opinions, advice or statements made on such websites and we do not make any representations or warranties about them. Third party linked websites and their contents should not be attributed to Heron Therapeutics, Inc. in any manner. We provide these hyperlinks merely as a convenience and the inclusion of such hyperlinks does not imply an endorsement of any product, service, individual, or entity.
Governing Law and Jurisdiction
Heron Therapeutics®, the Heron Therapeutics, Inc. logo, SUSTOL®, CINVANTI® and Biochronomer® (collectively, “Heron’s Marks”) are registered trademarks of Heron Therapeutics, Inc. Any use of Heron’s Marks except as permitted herein is prohibited and may be in violation of trademark law and other laws. Heron’s Marks and all other trademarks, logos, trade names, trade dress, service marks and products of Heron Therapeutics, Inc. (collectively with Heron’s Marks, “Marks”) displayed on our website are the property of Heron Therapeutics, Inc. or third parties, are protected in the United States and internationally and may not be used for advertising or publicity purposes, or to indicate any affiliation with or endorsement by Heron Therapeutics, Inc. These Marks may not be used in whole or in part without the prior written permission of such owners.
This Website is for US Audiences Only
Sign-Up for Email Updates
Receive news and updates on Heron’s latest innovations.